News NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.1367 ^USD	+3.25%		+3.01%	-76.83%

Apr. 08	Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors	CI
Apr. 03	NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors	Apr. 08	CI
NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding	Apr. 02	CI
NLS Pharmaceutics : Various Claims Against the Company - Form 6-K	Mar. 20	PU
NLS Pharmaceutics : SECOND ADDENDUM TO THE - Form 6-K	Mar. 20	PU
NLS Pharmaceutics Ltd. announced that it expects to receive $1.75 million in funding	Mar. 19	CI
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event	Mar. 15	AQ
NLS Pharmaceutics Submits Plan to Regain Listing Compliance with Nasdaq	Feb. 26	AQ
NLS Pharmaceutics Files Plan to Regain Nasdaq Listing Compliance	Feb. 23	MT
NLS Pharmaceutics - Notice of Deficiency with Nasdaq Continued Listing Requirements	Jan. 15	AQ
Press release titled: “NLS Pharmaceutics CEO Issues Letter to Shareholders.” - Form 6-K	Dec. 29	PU
NLS Pharmaceutics : Ordinary Shareholders’ Meeting Results - Form 6-K	Dec. 22	PU
NLS Pharmaceutics : UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS - Form 6-K	Dec. 06	PU
NLS Pharmaceutics AG Reports Earnings Results for the Half Year Ended June 30, 2023	Dec. 06	CI
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	Dec. 01	MT
Sector Update: Health Care Stocks Rise in Afternoon Trading	Dec. 01	MT
Top Midday Gainers	Dec. 01	MT
NLS Pharmaceutics Signs Option Agreement to Acquire Rights to Aexon Labs' Assets; Shares Rise	Dec. 01	MT
NLS Pharmaceutics Announces Election of Additional Board Members	Nov. 29	AQ
NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit, Deep Dive into Narcolepsy and Idiopathic Hypersomnia	Nov. 28	AQ
NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan	Nov. 17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

Summary

Filters